- Home
- ZLAB vs AMN Comparison
ZLAB vs AMN Comparison
Compare ZLAB & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- AMN
- Stock Information
- Founded
- ZLAB 2013
- AMN 1985
- Country
- ZLAB China
- AMN United States
- Employees
- ZLAB N/A
- AMN N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- AMN Assisted Living Services
- Sector
- ZLAB Health Care
- AMN Health Care
- Exchange
- ZLAB Nasdaq
- AMN Nasdaq
- Market Cap
- ZLAB 1.8B
- AMN 1.8B
- IPO Year
- ZLAB 2017
- AMN 2001
- Fundamental
- Price
- ZLAB $26.36
- AMN $42.43
- Analyst Decision
- ZLAB Strong Buy
- AMN Buy
- Analyst Count
- ZLAB 5
- AMN 7
- Target Price
- ZLAB $56.21
- AMN $65.00
- AVG Volume (30 Days)
- ZLAB 768.6K
- AMN 1.0M
- Earning Date
- ZLAB 11-12-2024
- AMN 11-07-2024
- Dividend Yield
- ZLAB N/A
- AMN N/A
- EPS Growth
- ZLAB N/A
- AMN N/A
- EPS
- ZLAB N/A
- AMN 2.60
- Revenue
- ZLAB $322,711,000.00
- AMN $3,233,295,000.00
- Revenue This Year
- ZLAB $48.34
- AMN N/A
- Revenue Next Year
- ZLAB $47.12
- AMN N/A
- P/E Ratio
- ZLAB N/A
- AMN $16.30
- Revenue Growth
- ZLAB 28.16
- AMN N/A
- 52 Week Low
- ZLAB $13.48
- AMN $36.50
- 52 Week High
- ZLAB $31.22
- AMN $80.22
- Technical
- Relative Strength Index (RSI)
- ZLAB 66.11
- AMN 49.28
- Support Level
- ZLAB $23.96
- AMN $39.96
- Resistance Level
- ZLAB $27.37
- AMN $41.13
- Average True Range (ATR)
- ZLAB 1.26
- AMN 1.64
- MACD
- ZLAB -0.03
- AMN 0.64
- Stochastic Oscillator
- ZLAB 72.56
- AMN 91.09
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About AMN AMN Healthcare Services Inc
AMN Healthcare Services is one of the largest healthcare staffing company in the United States. In 2023, it offered more than 13,000 nurses and allied healthcare full-time workers with provider clients nationwide. About two thirds of its business is generated from its temporary nursing division; the other third is generated from its physician placement and technology-backed workplace solutions divisions.